<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2374" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38715895</article-id><article-id pub-id-type="pmc">PMC11075076</article-id>
<article-id pub-id-type="doi">10.1002/deo2.374</article-id><article-id pub-id-type="publisher-id">DEO2374</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Radiomics analysis for prediction and classification of submucosal tumors based on gastrointestinal endoscopic ultrasonography</article-title><alt-title alt-title-type="left-running-head">ZHOU ET&#x000a0;AL.</alt-title></title-group><contrib-group><contrib id="deo2374-cr-0001" contrib-type="author"><name><surname>Zhou</surname><given-names>Hui</given-names></name><xref rid="deo2374-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2374-cr-0002" contrib-type="author" corresp="yes"><name><surname>Wei</surname><given-names>Guoliang</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-7728-9383</contrib-id><xref rid="deo2374-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>guoliang.wei@usst.edu.cn</email></address></contrib><contrib id="deo2374-cr-0003" contrib-type="author"><name><surname>Wu</surname><given-names>Junke</given-names></name><xref rid="deo2374-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="deo2374-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">College of Science</named-content>
<institution>University of Shanghai for Science and Technology</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><aff id="deo2374-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Business School</named-content>
<institution>University of Shanghai for Science and Technology</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Guoliang Wei, Business School, University of Shanghai for Science and Technology, Shanghai, China, 516 Jungong Road, Shanghai, China.<break/> Email: <email>guoliang.wei@usst.edu.cn</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="137">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e374</elocation-id><history>
<date date-type="rev-recd"><day>07</day><month>4</month><year>2024</year></date>
<date date-type="received"><day>19</day><month>2</month><year>2024</year></date>
<date date-type="accepted"><day>08</day><month>4</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Authors. <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e374.pdf"/><abstract><title>Abstract</title><sec id="deo2374-sec-0010"><title>Objectives</title><p>To identify and classify submucosal tumors by building and validating a radiomics model with gastrointestinal endoscopic ultrasonography (EUS) images.</p></sec><sec id="deo2374-sec-0020"><title>Methods</title><p>A total of 144 patients diagnosed with submucosal tumors through gastrointestinal EUS were collected between January 2019 and October 2020. There are 1952 radiomic features extracted from each patient's EUS images. The statistical test and the customized least absolute shrinkage and selection operator regression were used for feature selection. Subsequently, an extremely randomized trees algorithm was utilized to construct a robust radiomics classification model specifically tailored for gastrointestinal EUS images. The performance of the model was measured by evaluating the area under the receiver operating characteristic curve.</p></sec><sec id="deo2374-sec-0030"><title>Results</title><p>The radiomics model comprised 30 selected features that showed good discrimination performance in the validation cohorts. During validation, the area under the receiver operating characteristic curve was calculated as 0.9203 and the mean value after 10&#x02010;fold cross&#x02010;validation was 0.9260, indicating excellent stability and calibration. These results confirm the clinical utility of the model.</p></sec><sec id="deo2374-sec-0040"><title>Conclusions</title><p>Utilizing the dataset provided curated from gastrointestinal EUS examinations at our collaborating hospital, we have developed a well&#x02010;performing radiomics model. It can be used for personalized and non&#x02010;invasive prediction of the type of submucosal tumors, providing physicians with aid for early treatment and management of tumor progression.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2374-kwd-0001">endoscopic ultrasound</kwd><kwd id="deo2374-kwd-0002">extra trees</kwd><kwd id="deo2374-kwd-0003">radiomics</kwd><kwd id="deo2374-kwd-0004">submucosal tumor</kwd><kwd id="deo2374-kwd-0005">tumor classification</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>62273239</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="3"/><page-count count="9"/><word-count count="4584"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="deo2374-note-0001"><p>This work was supported in part by the Natural Science Foundation of China under Grant 62273239.</p></fn></fn-group></notes></front><body><sec id="deo2374-sec-0050"><title>INTRODUCTION</title><p>With the advancement of endoscopic ultrasonography (EUS) technology, the detection rates of submucosal tumors (SMTs) within the gastrointestinal tract have significantly increased.<xref rid="deo2374-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> These tumors, emerging from the pathological transformation of non&#x02010;epithelial mesenchymal tissues within the gastric wall, represent a diverse group of neoplastic lesions. They include gastric submucosal leiomyoma (GSL), neuroendocrine tumors (NETs), gastric ectopic pancreas (GEP), gastrointestinal stromal tumors (GIST), gastric mucosa lipoma (GML), and hemangiomas, among others, with GSL and GIST being notably prevalent.<xref rid="deo2374-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> The detection of SMTs often occurs incidentally during gastroscopy or is prompted by clinical symptoms related to the tumor's size and location, such as palpable abdominal masses, gastrointestinal bleeding, or abdominal pain. The European Society of Gastrointestinal Endoscopy guidelines from 2022 highlight the significance of early diagnosis in enhancing treatment outcomes by outlining indications for SMT treatment based on malignancy risk, symptomatic presentation, and considerations for patients undergoing bariatric surgery.<xref rid="deo2374-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo2374-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>Despite the benefits, traditional endoscopy primarily offers a superficial examination, limited in its capacity to visualize the deeper mucosal layers. Consequently, biopsy samples obtained during such procedures might not yield sufficient pathological information for an accurate determination of the tumor's nature, especially given the challenge of distinguishing between benign and malignant lesions.<xref rid="deo2374-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> EUS emerges as a superior modality by integrating the benefits of ultrasound and endoscopy, enabling detailed visualization of SMTs' external morphology and probing their origin layers, which is crucial for accurate pathology assessment and prognosis estimation.<xref rid="deo2374-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo2374-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Additionally, EUS provides invaluable insights into membrane integrity and other prognostic factors, thereby predicting surgical outcomes and enhancing patient management.<xref rid="deo2374-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> This study leverages EUS by concurrently acquiring white light images (WLI) and ultrasound images, playing a pivotal role in the precise identification of tumor types.</p><p>The digital age has led to an unprecedented gathering of patient and tumor data for research. Radiomics, a key player in medical imaging, uses sophisticated algorithms to identify numerous features from tumor images.<xref rid="deo2374-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="deo2374-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo2374-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> It transforms EUS images into detailed data, revealing patterns in tumor traits that traditional imaging might miss.<xref rid="deo2374-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo2374-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> As a revolutionary technique, radiomics converts images into detailed features, indicating pathological and physiological conditions.<xref rid="deo2374-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>,15</sup> Employing advanced algorithms, advances precision medicine, though challenges remain in representing SMTs with traditional features in our dataset. This study introduces wavelet and Laplacian of Gaussian (LoG) filters for better feature visibility, demonstrating their importance in classifying tumor types.<xref rid="deo2374-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>While traditional diagnostic methods like EUS&#x02010;guided fine&#x02010;needle aspiration and unroofing biopsy provide direct tissue analysis, radiomics offers a non&#x02010;invasive alternative, analyzing the entire lesion with potential for higher diagnostic accuracy and complementing these methods by identifying patterns not visible through conventional techniques.</p><p>We introduce a radiomics model underpinned by customized least absolute shrinkage and selection operator (MyLASSO) regression and the extremely randomized trees (Extra Trees) algorithm. Utilizing EUS&#x02010;obtained ultrasound images as model inputs, we adopted the area under the receiver operating characteristic curve (AUC) as the evaluation criterion. Our objective was to assess the ultrasound radiomics model's feasibility in accurately predicting various tumor types and identifying key features to ensure model stability and precision.</p></sec><sec id="deo2374-sec-0060"><title>MATERIALS AND METHODS</title><sec id="deo2374-sec-0070"><title>Patients</title><p>The data was obtained from the Gastrointestinal Endoscopy Center of Shanghai Sixth People's Hospital, affiliated with Shanghai Jiaotong University. It included 2042 images from 144 patients, gathered between January 2019 and October 2020. It spans various age groups and genders, ensuring a broad representation. The tumor cases included 57 GSLs, 39 GISTs, 10 NETs, 10 GEPs, and 15 GMLs. Thirteen atypical cases were omitted from the analysis due to limited representation, inadequate sample size, or other factors (Figure&#x000a0;<xref rid="deo2374-fig-0001" ref-type="fig">1</xref>). All patients provided informed consent, and the study adhered to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008), as confirmed by prior institutional committee approval. All patients underwent multimodal ultrasonography, including WLI and EUS. The final diagnoses for all patients were based on histopathological results from biopsies, including both surgical and endoscopic biopsies.</p><fig position="float" fig-type="FIGURE" id="deo2374-fig-0001"><label>FIGURE 1</label><caption><p>Flowchart for the exclusion of patients: Patients who are minors and whose pictures are not clear are first excluded; Patients who have inconclusive pathology results; The tumor has fewer than 10 patients or the tumor is not a submucosal tumor; for example, hemangioma. The numbers in brackets correspond to the number of cases excluded for each condition.</p></caption><graphic xlink:href="DEO2-5-e374-g002" position="anchor" id="jats-graphic-1"/></fig><p>The data encompasses patients' age, gender, and lesion location. The initial dataset, with a resolution of 764 &#x000d7; 572 pixels, contained extraneous details like dates, machine parameters, and corresponding WLI. These images were cropped to 388 &#x000d7; 457 pixels (Figure&#x000a0;<xref rid="deo2374-fig-0002" ref-type="fig">2</xref>). In this set, all ultrasound images were processed with wavelet and LoG filters to minimize ultrasound noise before feature extraction. Tumor location annotations and region of interest (ROI) segmentation were manually executed by skilled ultrasound doctors.</p><fig position="float" fig-type="FIGURE" id="deo2374-fig-0002"><label>FIGURE 2</label><caption><p>The data set: (a) The pixel size is 764 &#x000d7; 572, including dates, machine parameters, and so on. (b) The pixel size is 388 &#x000d7; 457, without irrelevant information.</p></caption><graphic xlink:href="DEO2-5-e374-g004" position="anchor" id="jats-graphic-3"/></fig><p>Inclusion criteria were as follows: (1) age &#x02265;18 years; (2) confirmed diagnosis of SMTs (including GSLs, GISTs, NETs, GEPs, and GMLs); (3) preoperative EUS examination; (4) exclusion of patients with indeterminate tumor types in the dataset. More details are shown in Figure&#x000a0;<xref rid="deo2374-fig-0001" ref-type="fig">1</xref>. In total, 131 patients were included in our study. The patients were randomly divided into a training group (<italic toggle="yes">n</italic> = 105) and a testing group (<italic toggle="yes">n</italic> = 26) in an 8:2 ratio. The clinical characteristics of all patients are shown in Table&#x000a0;<xref rid="deo2374-tbl-0001" ref-type="table">1</xref>. The baseline characteristics of patients in the training and test cohorts are shown in Table&#x000a0;<xref rid="deo2374-tbl-0002" ref-type="table">2</xref>. There were no statistically significant differences between the two cohorts.</p><table-wrap position="float" id="deo2374-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Clinical and histologic characteristics of the study population.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">GSL (<italic toggle="yes">n</italic> = 57)</th><th align="left" rowspan="1" colspan="1">GIST (<italic toggle="yes">n</italic> = 39)</th><th align="left" rowspan="1" colspan="1">NET (<italic toggle="yes">n</italic> = 10)</th><th align="left" rowspan="1" colspan="1">GEP (<italic toggle="yes">n</italic> = 10)</th><th align="left" rowspan="1" colspan="1">GML (<italic toggle="yes">n</italic> = 15)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)<italic toggle="yes">
<sup>a</sup>
</italic>
</td><td align="left" rowspan="1" colspan="1">55.54 &#x000b1; 10.153</td><td align="left" rowspan="1" colspan="1">59.41 &#x000b1; 10.197</td><td align="left" rowspan="1" colspan="1">49.80 &#x000b1; 14.688</td><td align="left" rowspan="1" colspan="1">44.10&#x000b1; 16.347</td><td align="left" rowspan="1" colspan="1">58.67 &#x000b1; 9.271</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">19 (33.3%)</td><td align="left" rowspan="1" colspan="1">19 (48.7%)</td><td align="left" rowspan="1" colspan="1">7 (70%)</td><td align="left" rowspan="1" colspan="1">4 (40%)</td><td align="left" rowspan="1" colspan="1">6 (40%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">38 (66.7%)</td><td align="left" rowspan="1" colspan="1">20 (51.3%)</td><td align="left" rowspan="1" colspan="1">3 (30%)</td><td align="left" rowspan="1" colspan="1">6 (60%)</td><td align="left" rowspan="1" colspan="1">9 (60%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Dominant lesion size<italic toggle="yes">
<sup>b</sup>
</italic>
</td><td align="left" rowspan="1" colspan="1">0.764 &#x000b1; 0.677</td><td align="left" rowspan="1" colspan="1">1.553 &#x000b1; 1.738</td><td align="left" rowspan="1" colspan="1">0.557 &#x000b1; 0.027</td><td align="left" rowspan="1" colspan="1">1.92 &#x000b1; 0.85</td><td align="left" rowspan="1" colspan="1">2.68 &#x000b1; 1.912</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.01<italic toggle="yes">
<sup>c</sup>
</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Uniformity of echo</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Uniformity</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Non&#x02010;uniformity</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Tumor location</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Esophagus</td><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Fundus</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stomach</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Duodenum</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rectum</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gastric sinus</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Colon</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo2374-tbl1-note-0001"><p>
<sup>a,b</sup>Data are mean &#x000b1; standard deviations.</p></fn><fn id="deo2374-tbl1-note-0002"><p>
<sup>c</sup>The <italic toggle="yes">p</italic>&#x02010;value between GSL and GEP was 0.004, but not analytical.</p></fn><fn id="deo2374-tbl1-note-0003"><p>Abbreviations: GEP, gastric ectopic pancreas; GIST, gastrointestinal stromal tumor; GML, gastric mucosa lipoma; GSL, gastric submucosal leiomyoma; NET, neuroendocrine tumor.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="deo2374-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Baseline characteristics of patients in the training and test cohort.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="plusmn" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="plusmn" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Age (years)</th><th align="left" rowspan="1" colspan="1">Gender</th><th align="left" rowspan="1" colspan="1">Male</th><th align="left" rowspan="1" colspan="1">Female</th><th align="left" rowspan="1" colspan="1">Dominant lesion size<italic toggle="yes">
<sup>b</sup>
</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GSL (<italic toggle="yes">n</italic> = 46) Training</td><td align="char" rowspan="1" colspan="1">55.19 &#x000b1; 10.497</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">15 (32.6%)</td><td align="char" rowspan="1" colspan="1">31 (67.4%)</td><td align="char" rowspan="1" colspan="1">0.831 &#x000b1; 0.623</td></tr><tr><td align="left" rowspan="1" colspan="1">GSL (<italic toggle="yes">n</italic> = 11) Test</td><td align="char" rowspan="1" colspan="1">57 &#x000b1; 8.854</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">4 (36.4%)</td><td align="char" rowspan="1" colspan="1">7 (63.6%)</td><td align="char" rowspan="1" colspan="1">0.713 &#x000b1; 0.598</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">p</italic>&#x02010;value</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.601</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.483</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">
<bold>0.839</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">GIST (<italic toggle="yes">n</italic> = 31) Training</td><td align="char" rowspan="1" colspan="1">60.322 &#x000b1; 9.914</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">15 (48.4%)</td><td align="char" rowspan="1" colspan="1">16 (51.6%)</td><td align="char" rowspan="1" colspan="1">1.479 &#x000b1; 1.694</td></tr><tr><td align="left" rowspan="1" colspan="1">GIST (<italic toggle="yes">n</italic> = 8) Test</td><td align="char" rowspan="1" colspan="1">55.875 &#x000b1; 11.192</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">4 (50%)</td><td align="char" rowspan="1" colspan="1">4 (50%)</td><td align="char" rowspan="1" colspan="1">1.683 &#x000b1; 1.833</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">p</italic>&#x02010;value</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.277</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.442</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">
<bold>0.934</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NET (<italic toggle="yes">n</italic> = 8) Training</td><td align="char" rowspan="1" colspan="1">53.5 &#x000b1; 15.128</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">6 (75%)</td><td align="char" rowspan="1" colspan="1">2 (25%)</td><td align="char" rowspan="1" colspan="1">0.586 &#x000b1; 0.021</td></tr><tr><td align="left" rowspan="1" colspan="1">NET (<italic toggle="yes">n</italic> = 2) Test</td><td align="char" rowspan="1" colspan="1">49 &#x000b1; 11.314</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">1 (50%)</td><td align="char" rowspan="1" colspan="1">1 (50%)</td><td align="char" rowspan="1" colspan="1">0.524 &#x000b1; 0.032</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">p</italic>&#x02010;value</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.352</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.401</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">
<bold>0.441</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">GEP (<italic toggle="yes">n</italic> = 8) Training</td><td align="char" rowspan="1" colspan="1">44.375 &#x000b1; 16.698</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">3 (37.5%)</td><td align="char" rowspan="1" colspan="1">5 (62.5%)</td><td align="char" rowspan="1" colspan="1">1.88 &#x000b1; 0.792</td></tr><tr><td align="left" rowspan="1" colspan="1">GEP (<italic toggle="yes">n</italic> = 2) Test</td><td align="char" rowspan="1" colspan="1">43 &#x000b1; 21.213</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">1 (50%)</td><td align="char" rowspan="1" colspan="1">1 (50%)</td><td align="char" rowspan="1" colspan="1">1.962 &#x000b1; 0.878</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">p</italic>&#x02010;value</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.922</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.398</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">
<bold>0.121</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">GML (<italic toggle="yes">n</italic> = 12) Training</td><td align="char" rowspan="1" colspan="1">59.75 &#x000b1; 9.687</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">5 (41.7%)</td><td align="char" rowspan="1" colspan="1">7 (58.3%)</td><td align="char" rowspan="1" colspan="1">2.59 &#x000b1; 1.736</td></tr><tr><td align="left" rowspan="1" colspan="1">GML (<italic toggle="yes">n</italic> = 3) Test</td><td align="char" rowspan="1" colspan="1">54.33 &#x000b1; 7.094</td><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">1 (33.3%)</td><td align="char" rowspan="1" colspan="1">2 (66.7%)</td><td align="char" rowspan="1" colspan="1">2.87 &#x000b1; 2.023</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">p</italic>&#x02010;value</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.385</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.476</bold>
</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">
<bold>0.478</bold>
</td></tr></tbody></table><table-wrap-foot><fn id="deo2374-tbl2-note-0001"><p>Abbreviations: GEP, gastric ectopic pancreas; GIST, gastrointestinal stromal tumor; GML, gastric mucosa lipoma; GSL, gastric submucosal leiomyoma; NET, neuroendocrine tumor.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2374-sec-0080"><title>Pathologic assessment of response</title><p>All lesion annotations were performed by more than three experienced pathologists who conducted histopathological examination and analysis to determine the tumor type. The final pathology results were then reviewed by dedicated gastrointestinal pathologists for further assessment, ensuring accurate pathological findings.</p></sec><sec id="deo2374-sec-0090"><title>Tumor masking</title><p>The patient's EUS images (including WLI) were analyzed by two radiologists (Dr. Li, a radiologist with 10 years of experience in tumor imaging, and Dr. Xia, a physician with 7 years of experience in tumor imaging). Both performed manual creation of regions of interest on the images under masking of histopathological findings (Figure&#x000a0;<xref rid="deo2374-fig-0003" ref-type="fig">3</xref>), including the entire tumor except the bowel lumen.</p><fig position="float" fig-type="FIGURE" id="deo2374-fig-0003"><label>FIGURE 3</label><caption><p>The workflow of the radiomics model construction. First, the dataset was labeled with ROIs after manual segmentation by the doctors; a total of 1952 features were extracted from the images that had been subjected to wavelet filters and LoG filters. Secondly, the Sankey diagram, statistical test, and MyLASSO were applied to the feature selection. Finally, the radiomics prediction model was constructed based on the selected features by Extra Trees. Abbreviations: MSE, mean square error; ROC, receiver operating characteristic; ROI, regions of interest; LoG, Laplacian of Gaussian; MyLASSO, the customized least absolute shrinkage and selection operator.</p></caption><graphic xlink:href="DEO2-5-e374-g003" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="deo2374-sec-0100"><title>Radiomic feature extraction and statistical analysis</title><p>All EUS images were taken with OLYMPUS EU&#x02010;ME3 at frequencies of 7.5 and 12 MHz. Clinical features included patient age, gender, tumor size, and so on (Table&#x000a0;<xref rid="deo2374-tbl-0001" ref-type="table">1</xref>). We extracted 1952 features from each EUS image: 216 original, 496 from wavelet decomposition, and 1240 from LoG filters. Radiomic features included shape, first&#x02010;order, and texture features, which comprised five categories: gray&#x02010;level dependence matrix (GLDM), gray&#x02010;level co&#x02010;occurrence matrix (GLCM), gray&#x02010;level run length matrix (GLRLM), gray&#x02010;level size zone matrix (GLSZM) and neighboring gray&#x02010;tone difference matrix (NGTDM). All of the radiomic features were extracted from three different image types (one original and two derived images) except the shape features. Wavelet features were obtained through wavelet decomposition, which can capture the high&#x02010;frequency information of the images and serve as an important component of image features. The LoG features combined texture information displaying various frequency scales and different feature orientations within the tumor volume.<xref rid="deo2374-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> These features have been widely used in previous radiomics studies.<xref rid="deo2374-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="deo2374-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p><p>Additionally, we categorized SMTs into five types: GSL (Label = 0), GIST (Label = 1), NET (Label = 2), GEP (Label = 3), and GML (Label = 4), and performed necessary statistical analysis. After removing defective data, we used Pearson's chi&#x02010;square test to compare tumor type differences based on attributes like age and gender. Statistical analyses were done with IBM SPSS Statistics 26.0, with significance levels at 0.05 or 0.01.</p></sec><sec id="deo2374-sec-0110"><title>Radiomics model construction</title><p>The radiomics signature workflow involves lesion segmentation, feature extraction, selection, and model analysis (Figure&#x000a0;<xref rid="deo2374-fig-0003" ref-type="fig">3</xref>). The model's efficacy was assessed using various machine learning models, with the Extra Trees model finalizing the tumor type classifications. This algorithm, a variation of Random Forest, selects suboptimal attributes. This reduces computational time, increases tree diversity, and offers strong generalization and noise resilience.</p><p>The best <mml:math id="jats-math-1" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> value that maximized the AUC of the subjects in the dataset was selected as the best regularisation parameter. After the choice of <mml:math id="jats-math-2" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> value, the radiomic score for each patient in the validation dataset was calculated using an extreme random forest model. Accuracy, AUC, sensitivity, and specificity values were calculated as metrics to assess the quantitative discrimination performance of radiomic features in this dataset (Table&#x000a0;<xref rid="deo2374-tbl-0003" ref-type="table">3</xref>).</p><table-wrap position="float" id="deo2374-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Ten&#x02010;fold cross&#x02010;validation of Extra Trees (full features and selected features).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Accuracy</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">AUC</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Sensitivity</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Specificity</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Fold</th><th align="left" rowspan="1" colspan="1">Full</th><th align="left" rowspan="1" colspan="1">Selected</th><th align="left" rowspan="1" colspan="1">Full</th><th align="left" rowspan="1" colspan="1">Selected</th><th align="left" rowspan="1" colspan="1">Full</th><th align="left" rowspan="1" colspan="1">Selected</th><th align="left" rowspan="1" colspan="1">Full</th><th align="left" rowspan="1" colspan="1">Selected</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.8235</td><td align="left" rowspan="1" colspan="1">0.7941</td><td align="left" rowspan="1" colspan="1">0.9548</td><td align="left" rowspan="1" colspan="1">0.9397</td><td align="left" rowspan="1" colspan="1">0.8235</td><td align="left" rowspan="1" colspan="1">0.7941</td><td align="left" rowspan="1" colspan="1">0.8537</td><td align="left" rowspan="1" colspan="1">0.8348</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.7353</td><td align="left" rowspan="1" colspan="1">0.7647</td><td align="left" rowspan="1" colspan="1">0.9349</td><td align="left" rowspan="1" colspan="1">0.9585</td><td align="left" rowspan="1" colspan="1">0.7353</td><td align="left" rowspan="1" colspan="1">0.7647</td><td align="left" rowspan="1" colspan="1">0.6825</td><td align="left" rowspan="1" colspan="1">0.7051</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.7273</td><td align="left" rowspan="1" colspan="1">0.7576</td><td align="left" rowspan="1" colspan="1">0.9293</td><td align="left" rowspan="1" colspan="1">0.9136</td><td align="left" rowspan="1" colspan="1">0.7273</td><td align="left" rowspan="1" colspan="1">0.7576</td><td align="left" rowspan="1" colspan="1">0.7446</td><td align="left" rowspan="1" colspan="1">0.7748</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8182</td><td align="left" rowspan="1" colspan="1">0.9301</td><td align="left" rowspan="1" colspan="1">0.9268</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8182</td><td align="left" rowspan="1" colspan="1">0.8273</td><td align="left" rowspan="1" colspan="1">0.8275</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">0.7273</td><td align="left" rowspan="1" colspan="1">0.6970</td><td align="left" rowspan="1" colspan="1">0.8480</td><td align="left" rowspan="1" colspan="1">0.8795</td><td align="left" rowspan="1" colspan="1">0.7273</td><td align="left" rowspan="1" colspan="1">0.6970</td><td align="left" rowspan="1" colspan="1">0.7455</td><td align="left" rowspan="1" colspan="1">0.6713</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8182</td><td align="left" rowspan="1" colspan="1">0.9109</td><td align="left" rowspan="1" colspan="1">0.9200</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8182</td><td align="left" rowspan="1" colspan="1">0.7441</td><td align="left" rowspan="1" colspan="1">0.8263</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">0.6364</td><td align="left" rowspan="1" colspan="1">0.6870</td><td align="left" rowspan="1" colspan="1">0.8350</td><td align="left" rowspan="1" colspan="1">0.8820</td><td align="left" rowspan="1" colspan="1">0.6364</td><td align="left" rowspan="1" colspan="1">0.6870</td><td align="left" rowspan="1" colspan="1">0.6320</td><td align="left" rowspan="1" colspan="1">0.6992</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8485</td><td align="left" rowspan="1" colspan="1">0.8863</td><td align="left" rowspan="1" colspan="1">0.9488</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8485</td><td align="left" rowspan="1" colspan="1">0.7966</td><td align="left" rowspan="1" colspan="1">0.8538</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8485</td><td align="left" rowspan="1" colspan="1">0.9650</td><td align="left" rowspan="1" colspan="1">0.9704</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.8485</td><td align="left" rowspan="1" colspan="1">0.7413</td><td align="left" rowspan="1" colspan="1">0.8057</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.7273</td><td align="left" rowspan="1" colspan="1">0.9283</td><td align="left" rowspan="1" colspan="1">0.9213</td><td align="left" rowspan="1" colspan="1">0.7879</td><td align="left" rowspan="1" colspan="1">0.7273</td><td align="left" rowspan="1" colspan="1">0.7414</td><td align="left" rowspan="1" colspan="1">0.7100</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean</td><td align="left" rowspan="1" colspan="1">0.7589</td><td align="left" rowspan="1" colspan="1">0.7771</td><td align="left" rowspan="1" colspan="1">0.9123</td><td align="left" rowspan="1" colspan="1">0.9260</td><td align="left" rowspan="1" colspan="1">0.7589</td><td align="left" rowspan="1" colspan="1">0.7771</td><td align="left" rowspan="1" colspan="1">0.7509</td><td align="left" rowspan="1" colspan="1">0.7708</td></tr><tr><td align="left" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1">0.0509</td><td align="left" rowspan="1" colspan="1">0.0545</td><td align="left" rowspan="1" colspan="1">0.0409</td><td align="left" rowspan="1" colspan="1">0.0284</td><td align="left" rowspan="1" colspan="1">0.0509</td><td align="left" rowspan="1" colspan="1">0.0545</td><td align="left" rowspan="1" colspan="1">0.0613</td><td align="left" rowspan="1" colspan="1">0.0645</td></tr></tbody></table><table-wrap-foot><fn id="deo2374-tbl3-note-0001"><p>Abbreviation: SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2374-sec-0120"><title>Feature selection method</title><p>To minimize overfitting in the final model, we first excluded features without significant tumor type differences. We then applied the customized LASSO algorithm, which sets coefficients of less significant features to zero. The model (MyLASSO) is defined as follows:
<disp-formula id="deo2374-disp-0001">
<mml:math id="jats-math-3" display="block"><mml:mrow><mml:mrow><mml:mspace width="0.33em"/><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>&#x003b2;</mml:mi><mml:mspace width="0.33em"/></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>For patients with GSL <mml:math id="jats-math-4" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math>; for patients with GIST <mml:math id="jats-math-5" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>; for patients with NET <mml:math id="jats-math-6" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>2</mml:mn></mml:mrow></mml:mrow></mml:math>; for patients with GEP <mml:math id="jats-math-7" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:math>; for patients with GML <mml:math id="jats-math-8" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>4</mml:mn></mml:mrow></mml:mrow></mml:math>; <mml:math id="jats-math-9" display="inline"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math> is the total number of features used in the model; <mml:math id="jats-math-10" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mspace width="0.33em"/><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mtext>&#x02026;</mml:mtext><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math> is the different features for each case, <mml:math id="jats-math-11" display="inline"><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:math> is the number of cases; <mml:math id="jats-math-12" display="inline"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mspace width="0.33em"/><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mtext>&#x02026;</mml:mtext><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math> is the parameter of the model, and <mml:math id="jats-math-13" display="inline"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math> is the error term.</p><p>The MyLASSO algorithm uses regularization to pare down parameter values, simplifying the model while keeping key features. Its objective function has a data fitting term (minimizing squared residuals) and a penalty term (penalizing model parameter absolute values). This penalty increases with the regularization parameter <mml:math id="jats-math-14" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math>, making the model focus on fewer crucial features as <mml:math id="jats-math-15" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> rises.</p><p>Its optimization problem can be expressed as minimizing the following cost function:
<disp-formula id="deo2374-disp-0002">
<mml:math id="jats-math-16" display="block"><mml:mrow><mml:mrow><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mspace width="0.33em"/><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:msup><mml:mfenced close="]" open="[" separators=""><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>S</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mspace width="0.33em"/><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo linebreak="badbreak">+</mml:mo><mml:mi>&#x003bb;</mml:mi><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mspace width="0.33em"/><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mfenced close="|" open="|" separators=""><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-17" display="inline"><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math> is the outcome for patient <mml:math id="jats-math-18" display="inline"><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:math>, <mml:math id="jats-math-19" display="inline"><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:math> is the number of patients, <mml:math id="jats-math-20" display="inline"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:math> is the sigmoid function, <mml:math id="jats-math-21" display="inline"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math> is the <mml:math id="jats-math-22" display="inline"><mml:mrow><mml:msub><mml:mi>j</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math> feature of the <mml:math id="jats-math-23" display="inline"><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math> patient and <mml:math id="jats-math-24" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> is the regularization parameter. The sigmoid function <mml:math id="jats-math-25" display="inline"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:math> is defined as follows:
<disp-formula id="deo2374-disp-0003">
<mml:math id="jats-math-26" display="block"><mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mspace width="0.33em"/><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mi>e</mml:mi><mml:mi>x</mml:mi></mml:msup></mml:mfrac><mml:mspace width="0.33em"/></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>The MyLASSO penalty <mml:math id="jats-math-27" display="inline"><mml:mrow><mml:mrow><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mspace width="0.33em"/><mml:mo>=</mml:mo><mml:mspace width="0.33em"/><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math> was applied in order to set some parameters <mml:math id="jats-math-28" display="inline"><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math> to zero, which can generate a sparse model. Finally, the algorithm selected features with greater contributions.</p></sec></sec><sec id="deo2374-sec-0130"><title>RESULTS</title><sec id="deo2374-sec-0140"><title>Clinical characteristics</title><p>Table&#x000a0;<xref rid="deo2374-tbl-0001" ref-type="table">1</xref> lists patients' clinical details. With an average age of 55.81 &#x000b1; 11.689 years, 40.85% were male, and 58.45% were female. Figure&#x000a0;<xref rid="deo2374-fig-0003" ref-type="fig">3</xref>&#x02019;s Sankey diagrams depict tumor type distribution by gender. Continuous variables were analyzed using mean &#x000b1; SD and t&#x02010;tests; categorical ones used chi&#x02010;square tests. Statistical analysis results for the training and test groups, including age, gender, tumor size, and their <italic toggle="yes">p</italic>&#x02010;values, are shown in Table&#x000a0;<xref rid="deo2374-tbl-0002" ref-type="table">2</xref>. Results revealed no significant age or gender differences across tumor types, deeming them non&#x02010;influential in tumor classification.</p><p>Most tumors predominantly affected females, except for NET due to fewer cases. All intergroup <italic toggle="yes">p</italic>&#x02010;values were above 0.05, suggesting no notable associations. Although tumor sizes varied little, GSL and NET were typically smaller, while GIST, GEP, and GML were larger. Different tumors had distinct ultrasound echoes, emphasizing in&#x02010;depth ultrasound image feature analysis.</p></sec><sec id="deo2374-sec-0150"><title>Model selection</title><p>The dataset consists of 475 lesion images, with 428 for model training and 47 for evaluation. The model utilized all 1952 extracted features from each image and assessed performance using the AUC value. A higher AUC value is deemed superior to accuracy in Radiomics.<xref rid="deo2374-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> After examination, the Extra Trees Classifier achieved the highest AUC value of 0.8998, making it the final classification model.</p><p>To further validate the stability of the Extra Trees model, 10&#x02010;fold cross&#x02010;validation was performed on the dataset. This approach helps reduce the impact of random variations and detect and mitigate the risk of overfitting. It helps to capture the performance of the model on the entire dataset and provides an objective assessment of its generalization ability.<xref rid="deo2374-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> From Table&#x000a0;<xref rid="deo2374-tbl-0003" ref-type="table">3</xref>, the average AUC is 0.9123 (0.8350&#x02013;0.9650), indicating good stability of our model (Figure&#x000a0;<xref rid="deo2374-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="deo2374-fig-0004"><label>FIGURE 4</label><caption><p>Results of classification predictions by the customized Radiomics model: (a) Results of selected features; (b) ROC of the model (selected features); (c) PR curve of the model (selected features); (d) Results of full features; (e) ROC of the model (full features); (f) PR curve of the model (full features).</p><p>Abbreviations: ROC, the receiver operating characteristic curve; PR curve, the precision&#x02010;recall curve.</p></caption><graphic xlink:href="DEO2-5-e374-g001" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="deo2374-sec-0160"><title>Feature selection and radiomics model construction</title><p>This study utilized a variety of statistical methods to analyze medical imaging data. Weighted feature ranking was conducted on all attributes, as feature extraction is pivotal in data processing. We adopted a multi&#x02010;stage feature extraction method.</p><p>The independent samples t&#x02010;test was used to assess relationships between features. Multivariate regression analysis evaluated the significance of each feature's regression coefficient. We organized the <italic toggle="yes">p</italic>&#x02010;values in ascending sequence, and the top 33% of features (around 633 features) underwent further scrutiny. This phase aimed to discard non&#x02010;influential features, minimizing data noise and redundancy.</p><p>To further optimize the feature subset, we applied MyLASSO regression to the remaining features for dimensionality reduction. By this method, we achieved dimensionality reduction and optimization of the data. We experimented with different values of <mml:math id="jats-math-29" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> ranging from <mml:math id="jats-math-30" display="inline"><mml:mrow><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math> to <mml:math id="jats-math-31" display="inline"><mml:mrow><mml:msup><mml:mn>10</mml:mn><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math> and recorded the coefficients of the MyLASSO models corresponding to each value (Figure&#x000a0;<xref rid="deo2374-fig-0003" ref-type="fig">3</xref>).</p><p>The optimal <mml:math id="jats-math-32" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> value was selected as <mml:math id="jats-math-33" display="inline"><mml:mrow><mml:mrow><mml:mn>2.54</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>, and the relationship graph (Figure&#x000a0;<xref rid="deo2374-fig-0003" ref-type="fig">3</xref>) between MSE and <mml:math id="jats-math-34" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> demonstrated that this particular <mml:math id="jats-math-35" display="inline"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math> value indeed produced the best results. These coefficients represent the importance of features in the model. We identified 30 key features in our study.</p><p>To assess the performance of the selected features, we calculated the root mean squared error (RMSE), resulting in a value of 1.374.
<disp-formula id="deo2374-disp-0004">
<mml:math id="jats-math-36" display="block"><mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:msqrt><mml:mrow><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msqrt><mml:mo linebreak="goodbreak">=</mml:mo><mml:msqrt><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac><mml:msubsup><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:msup><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>y</mml:mi><mml:mo>&#x0005e;</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>This indicates that the extracted features demonstrate good predictive performance in current processing tasks.</p></sec><sec id="deo2374-sec-0170"><title>Analysis</title><p>Using the Extra Trees model, we re&#x02010;classified and predicted the 30 re&#x02010;extracted features, with results shown in Figure&#x000a0;<xref rid="deo2374-fig-0004" ref-type="fig">4a&#x02013;c</xref>. The results showcase strong classification performance: over 80% accuracy for GSL, GIST, GEP, and 100% for GML. However, the NET's smaller sample size limited its prediction accuracy to 75%. The precision&#x02010;recall (PR) curve of the model is depicted in Figure&#x000a0;<xref rid="deo2374-fig-0004" ref-type="fig">4c</xref>, revealing impressive outcomes. Figure&#x000a0;<xref rid="deo2374-fig-0004" ref-type="fig">4d&#x02013;f</xref> contrasts the performance with the full feature set, whereas Figure&#x000a0;<xref rid="deo2374-fig-0004" ref-type="fig">4a&#x02013;c</xref> highlights superior results.</p><p>We also evaluated our prediction model with 10&#x02010;fold cross&#x02010;validation (Table&#x000a0;<xref rid="deo2374-tbl-0003" ref-type="table">3</xref>) to gauge its tumor classification proficiency. Compared with Table&#x000a0;<xref rid="deo2374-tbl-0003" ref-type="table">3</xref>, the model shows enhanced performance versus the full dataset. The elevated AUC implies the feature selection process effectively weeded out redundant or detrimental features. The model's average AUC of 0.9260 underscores its precision in distinguishing lesion types&#x02014;essential for medical image classification. The model's mean values for sensitivity (0.7771) and specificity (0.7708) emphasize its capacity to correctly identify positive samples, crucial for early disease detection and minimizing false negatives.</p><p>In summary, our radiomics classification model, based on 10&#x02010;fold cross&#x02010;validation results, boasts high AUC, sensitivity, and specificity&#x02014;affirming its accuracy, consistency, and vital role in tumor diagnosis and research.</p></sec></sec><sec id="deo2374-sec-0180"><title>DISCUSSION</title><p>This study introduces an innovative radiomics model for identifying and classifying SMTs using EUS images. Analyzing EUS images from 144 patients, we extracted 1952 radiomic features. A rigorous process involving statistical testing and a custom LASSO regression identified 30 key features with significant discriminatory ability. These features underpinned a model with impressive diagnostic accuracy, indicated by an average AUC of 0.9260, and showed stability and calibration in validation cohorts.</p><p>Radiomics represents a significant step forward in diagnosing complex tumors, marking a first in SMT classification.<xref rid="deo2374-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> It effectively captures comprehensive tumor data, offering insights into tumor characteristics previously unachievable with conventional methods.<xref rid="deo2374-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> This research has vital clinical implications, particularly in preoperative diagnosis and treatment planning for SMTs, which, despite being mostly benign, can cause psychological stress and require surgical intervention, affecting recovery times.<xref rid="deo2374-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>
</p><p>Our findings highlight radiomics' potential in SMT diagnosis automation, contrasting with recent studies like Binglan Zhang et&#x000a0;al.&#x02019;s work on using artificial intelligence for GIST diagnosis via EUS images, and another study's examination of artificial intelligence&#x000a0;with contrast&#x02010;enhanced harmonic EUS for differentiating GISTs from leiomyomas.<xref rid="deo2374-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="deo2374-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Our approach encompasses a wider range of SMT classifications, demonstrating broader applicability and enhancing diagnostic methodologies in the field.</p><p>Compared to traditional diagnostic methods such as EUS fine&#x02010;needle aspiration, unroofing biopsy, or mucosal incision&#x02010;assisted biopsy, the methodology presented in this work, through detailed imaging feature extraction, achieves a non&#x02010;invasive and more comprehensive analysis of lesions. This represents a significant advancement over conventional invasive techniques, which are susceptible to sampling errors. The adoption of radiomics in medical diagnostic processes signifies a shift towards less invasive, more informative diagnostic practices, potentially revolutionizing the clinical decision&#x02010;making process for SMTs.</p><p>Nonetheless, our study is not devoid of limitations. The sample size, albeit sufficient for preliminary analysis, remains modest and warrants expansion in future research endeavors to enhance the model's generalizability and robustness. Additionally, the singular source of our data set&#x02014;a lone medical center&#x02014;could potentially introduce bias and limit the applicability of our findings across diverse clinical settings. Future studies are encouraged to embrace a multicentric approach, incorporating data from various geographical and demographic backgrounds to fortify the external validity of the model.</p><p>Radiomics is rapidly advancing, with improvements in imaging technologies and algorithms expected to enhance radiomic models' diagnostic accuracy and utility. Integrating radiomics with other diagnostic tools like MRI or CT could offer a more holistic approach to diagnosing SMTs.</p><p>In conclusion, our radiomics model signifies a significant step forward in the non&#x02010;invasive diagnosis of SMTs, offering a novel tool that potentially aids clinicians in the early detection, classification, and management of these tumors. Despite the highlighted limitations, this study paves the way for future research, emphasizing the need for larger, multicentric studies and the exploration of advanced imaging modalities to enhance the diagnostic landscape for SMTs.</p></sec><sec sec-type="COI-statement" id="deo2374-sec-0200"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec></body><back><ack id="deo2374-sec-0190"><title>ACKNOWLEDGMENTS</title><p>This experimental dataset was provided by the Gastrointestinal Endoscopy Center of Shanghai Sixth People's Hospital Affiliated with Shanghai Jiaotong University. We would like to express our gratitude to Director Xinjian Wan and Dr. Xiangyun Zhao for their great support of this project.</p></ack><ref-list id="deo2374-bibl-0001"><title>REFERENCES</title><ref id="deo2374-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2374-cit-0001">
<string-name>
<surname>Guo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endosonography&#x02010;assisted diagnosis and therapy of gastrointestinal submucosal tumors</article-title>. <source>Endosc Ultrasound</source>
<year>2013</year>; <volume>2</volume>: <fpage>125</fpage>&#x02013;<lpage>133</lpage>.<pub-id pub-id-type="pmid">24949380</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2374-cit-0002">
<string-name>
<surname>Al&#x02010;Share</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Alloghbi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Al Hallak</surname>
<given-names>MN</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Gastrointestinal stromal tumor: A review of current and emerging therapies</article-title>. <source>Cancer Metastasis Rev</source>
<year>2021</year>; <volume>40</volume>: <fpage>625</fpage>&#x02013;<lpage>641</lpage>.<pub-id pub-id-type="pmid">33876372</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2374-cit-0003">
<string-name>
<surname>Deprez</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Moons</surname>
<given-names>LMG</given-names>
</string-name>, <string-name>
<surname>O&#x002bc;Toole</surname>
<given-names>D</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline</article-title>. <source>Endoscopy</source>
<year>2022</year>; <volume>54</volume>: <fpage>412</fpage>&#x02013;<lpage>429</lpage>.<pub-id pub-id-type="pmid">35180797</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2374-cit-0004">
<string-name>
<surname>Lu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhuo</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>Q</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic ultrasonography is useful for predicting perforation in the endoscopic resection of gastric submucosal tumors originating from the muscularis propria: A retrospective case&#x02010;control study</article-title>. <source>Ultrasonography</source>
<year>2023</year>; <volume>42</volume>: <fpage>78</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">36458370</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2374-cit-0005">
<string-name>
<surname>Kuwahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Current status of artificial intelligence analysis for endoscopic ultrasonography</article-title>. <source>Dig Endosc</source>
<year>2021</year>; <volume>33</volume>: <fpage>298</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">33098123</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2374-cit-0006">
<string-name>
<surname>Ke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>D</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Extraluminal laparoscopic wedge resection of gastric submucosal tumors: A retrospective review of 84 cases</article-title>. <source>Surg Endosc</source>
<year>2010</year>; <volume>24</volume>: <fpage>1962</fpage>&#x02013;<lpage>1968</lpage>.<pub-id pub-id-type="pmid">20135174</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2374-cit-0007">
<string-name>
<surname>Kida</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawaguchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Miyata</surname>
<given-names>E</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic ultrasonography diagnosis of subepithelial lesions</article-title>. <source>Dig Endosc</source>
<year>2017</year>; <volume>29</volume>: <fpage>431</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="pmid">28258621</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2374-cit-0008">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Hyperechoic demarcation line between a tumor and the muscularis propria layer as a marker for deciding the endoscopic treatment of gastric submucosal tumor</article-title>. <source>J Zhejiang Univ Sci B</source>
<year>2017</year>; <volume>18</volume>: <fpage>707</fpage>&#x02013;<lpage>716</lpage>.<pub-id pub-id-type="pmid">28786245</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2374-cit-0009">
<string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y&#x02010;J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer</article-title>. <source>Clin Cancer Res</source>
<year>2017</year>; <volume>23</volume>: <fpage>7253</fpage>&#x02013;<lpage>7262</lpage>.<pub-id pub-id-type="pmid">28939744</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2374-cit-0010">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A novel multimodal radiomics model for preoperative prediction of lymphovascular invasion in rectal cancer</article-title>. <source>Front Oncol</source>
<year>2020</year>; <volume>10</volume>: <fpage>457</fpage>.<pub-id pub-id-type="pmid">32328460</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo2374-cit-0011">
<string-name>
<surname>Wesdorp</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Hellingman</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jansma</surname>
<given-names>EP</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Advanced analytics and artificial intelligence in gastrointestinal cancer: A systematic review of radiomics predicting response to treatment</article-title>. <source>Eur J Nucl Med Mol Imaging</source>
<year>2021</year>; <volume>48</volume>: <fpage>1785</fpage>&#x02013;<lpage>1794</lpage>.<pub-id pub-id-type="pmid">33326049</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo2374-cit-0012">
<string-name>
<surname>Lambin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rios&#x02010;Velazquez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Leijenaar</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Radiomics: Extracting more information from medical images using advanced feature analysis</article-title>. <source>Eur J Cancer</source>
<year>2012</year>; <volume>48</volume>: <fpage>441</fpage>&#x02013;<lpage>446</lpage>.<pub-id pub-id-type="pmid">22257792</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo2374-cit-0013">
<string-name>
<surname>Parmar</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Grossmann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bussink</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Machine learning methods for quantitative radiomic biomarkers</article-title>. <source>Sci Rep</source>
<year>2015</year>; <volume>5</volume>: <elocation-id>13087</elocation-id>.<pub-id pub-id-type="pmid">26278466</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo2374-cit-0014">
<string-name>
<surname>Gillies</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Kinahan</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Hricak</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Radiomics: Images are more than pictures, they are data</article-title>. <source>Radiology</source>
<year>2016</year>; <volume>278</volume>: <fpage>563</fpage>&#x02013;<lpage>577</lpage>.<pub-id pub-id-type="pmid">26579733</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo2374-cit-0015">
<string-name>
<surname>Acharya</surname>
<given-names>UR</given-names>
</string-name>, <string-name>
<surname>Hagiwara</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sudarshan</surname>
<given-names>VK</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Towards precision medicine: From quantitative imaging to radiomics</article-title>. <source>J Zhejiang Univ Sci B</source>
<year>2018</year>; <volume>19</volume>: <fpage>6</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">29308604</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo2374-cit-0016">
<string-name>
<surname>Hattori</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Matsunaga</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takamochi</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin&#x02010;section computed tomography</article-title>. <source>Lung Cancer</source>
<year>2017</year>; <volume>113</volume>: <fpage>7</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">29110852</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo2374-cit-0017">
<string-name>
<surname>Aerts</surname>
<given-names>HJWL</given-names>
</string-name>, <string-name>
<surname>Velazquez</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Leijenaar</surname>
<given-names>RTH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Correction: Corrigendum: Decoding tumor phenotype by noninvasive imaging using a quantitative radiomics approach</article-title>. <source>Nat Commun</source>
<year>2014</year>; <volume>5</volume>: <fpage>4644</fpage>.</mixed-citation></ref><ref id="deo2374-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo2374-cit-0018">
<string-name>
<surname>Itakura</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Achrol</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Mitchell</surname>
<given-names>LA</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities</article-title>. <source>Sci Transl Med</source>
<year>2015</year>; <volume>7</volume>: <elocation-id>303ra138</elocation-id>.</mixed-citation></ref><ref id="deo2374-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo2374-cit-0019">
<string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer</article-title>. <source>J Clin Oncol</source>
<year>2016</year>; <volume>34</volume>: <fpage>2157</fpage>&#x02013;<lpage>2164</lpage>.<pub-id pub-id-type="pmid">27138577</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo2374-cit-0020">
<string-name>
<surname>Mandrekar</surname>
<given-names>JN</given-names>
</string-name>. <article-title>Receiver operating characteristic curve in diagnostic test assessment</article-title>. <source>J Thorac Oncol</source>
<year>2010</year>; <volume>5</volume>: <fpage>1315</fpage>&#x02013;<lpage>1316</lpage>.<pub-id pub-id-type="pmid">20736804</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0021"><label>21</label><mixed-citation publication-type="miscellaneous" id="deo2374-cit-0021">
<string-name>
<surname>Kohavi</surname>
<given-names>R</given-names>
</string-name>. <article-title>A study of cross&#x02010;validation and bootstrap for accuracy estimation and model selection</article-title>. <year>1995</year>.</mixed-citation></ref><ref id="deo2374-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo2374-cit-0022">
<string-name>
<surname>Chang</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Joel</surname>
<given-names>MZ</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>HY</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparison of radiomic feature aggregation methods for patients with multiple tumors</article-title>. <source>Sci Rep</source>
<year>2021</year>; <volume>11</volume>: <fpage>9758</fpage>.<pub-id pub-id-type="pmid">33963236</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo2374-cit-0023">
<string-name>
<surname>Chuanji</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Shaolv</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparative study of radiomics, tumor morphology, and clinicopathological factors in predicting overall survival of patients with rectal cancer before surgery</article-title>. <source>Transl Oncol</source>
<year>2022</year>; <volume>18</volume>: <elocation-id>101352</elocation-id>.<pub-id pub-id-type="pmid">35144092</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo2374-cit-0024">
<string-name>
<surname>Lv</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>X</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Risk stratification in patients with upper gastrointestinal submucosal tumors undergoing submucosal tunnel endoscopic resection</article-title>. <source>Front Med</source>
<year>2022</year>; <volume>9</volume>: <elocation-id>1067576</elocation-id>.</mixed-citation></ref><ref id="deo2374-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo2374-cit-0025">
<string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>P</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Artificial intelligence&#x02010;assisted endoscopic ultrasound in the diagnosis of gastrointestinal stromal tumors: A meta&#x02010;analysis</article-title>. <source>Surg Endosc</source>
<year>2023</year>; <volume>37</volume>: <fpage>1649</fpage>&#x02013;<lpage>1657</lpage>.<pub-id pub-id-type="pmid">36100781</pub-id>
</mixed-citation></ref><ref id="deo2374-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo2374-cit-0026">
<string-name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kamata</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Value of artificial intelligence with novel tumor tracking technology in the diagnosis of gastric submucosal tumors by contrast&#x02010;enhanced harmonic endoscopic ultrasonography</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2022</year>; <volume>37</volume>: <fpage>841</fpage>&#x02013;<lpage>846</lpage>.<pub-id pub-id-type="pmid">35043456</pub-id>
</mixed-citation></ref></ref-list></back></article>